Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.

Sci Rep · 2021 · PMC7803770 · PMID 33436905

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

BXM-treated patients showed a trend to increased values of both activated and effector memory CD8+ T-cell over the 1-year follow-up, whereas no differences were found in CD4+ T-cells (Supplemental Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.